This application serves as a competitive reapplication ofthe Center of Excellence in Molecular Hematology at the Children's Hospital Boston. The goal of the Center is to facilitate fundamental Studies of the blood system in the two most tractable model organisms~the mouse and zebrafish. Focus on these two systems leverages the advantages of each, while providing the benefits of synergy from parallel developmental and genetic studies. The Center is comprised of 3 cores that serve the users within the Harvard Medical area and elsewhere. CORE A provides consultation and resources for generation of engineered mice and ES cells, distribution of mutant strains and various CRE-expressing and CRE-reporter lines, and assistance in analysis of mouse phenotypes and bone marrow transplantation CORE B is a zebrafish core that supports genetics and developmental studies of hematopoiesis. CORE B maintains numerous mutant zebrafish stocks, and provides education to users. CORE C is a new core focused on technology aimed at supporting research on hematopoietic stem cells and individual blood lineages. One part of CORE C is a fee-for-service flow cytometry core that allows for characterization and isolation of hematopoietic cell populations. A complementary part of CORE C is devoted to technology development and dissemination of methodologies for genomic analyses of small numbers of cells. Specifically, CORE C will validate antibodies for ChlP-sequencing and ChlP-Chip approaches, and improve methods for application of these and other methods (such as genome-wide assessment of DNA methylation) to limited numbers of cells isolated by FACS. CORE C will fulfill an unmet need in the hematology community. In addition to the CORES, the Center will provide an Enrichment Program consisting of workshops and Internet meetings, as well as a Pilot Grant Program designed to support emerging investigators or to recruit new investigators to hematology.

Public Health Relevance

Research in the area of developmental molecular hematology is fundamental to an improved understanding of disorders affecting blood cell production and function. Such research is central to the mission of the NIDDK hematology program.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK049216-21
Application #
8695327
Study Section
Special Emphasis Panel (ZDK1-GRB-G)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
21
Fiscal Year
2014
Total Cost
$398,987
Indirect Cost
$166,256
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Vo, Linda T; Kinney, Melissa A; Liu, Xin et al. (2018) Regulation of embryonic haematopoietic multipotency by EZH1. Nature 553:506-510
Mandelbaum, Joseph; Shestopalov, Ilya A; Henderson, Rachel E et al. (2018) Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma. J Exp Med 215:2673-2685
Yamauchi, Takuji; Masuda, Takeshi; Canver, Matthew C et al. (2018) Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS. Cancer Cell 33:386-400.e5
Blaser, Bradley W; Zon, Leonard I (2018) Making HSCs in vitro: don't forget the hemogenic endothelium. Blood 132:1372-1378
Cesana, Marcella; Guo, Michael H; Cacchiarelli, Davide et al. (2018) A CLK3-HMGA2 Alternative Splicing Axis Impacts Human Hematopoietic Stem Cell Molecular Identity throughout Development. Cell Stem Cell 22:575-588.e7
Blaser, Bradley W; Moore, Jessica L; Hagedorn, Elliott J et al. (2017) CXCR1 remodels the vascular niche to promote hematopoietic stem and progenitor cell engraftment. J Exp Med 214:1011-1027
Perlin, Julie R; Robertson, Anne L; Zon, Leonard I (2017) Efforts to enhance blood stem cell engraftment: Recent insights from zebrafish hematopoiesis. J Exp Med 214:2817-2827
Doulatov, Sergei; Vo, Linda T; Macari, Elizabeth R et al. (2017) Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors. Sci Transl Med 9:
Lessard, Samuel; Francioli, Laurent; Alfoldi, Jessica et al. (2017) Human genetic variation alters CRISPR-Cas9 on- and off-targeting specificity at therapeutically implicated loci. Proc Natl Acad Sci U S A 114:E11257-E11266
Perlin, Julie R; Sporrij, Audrey; Zon, Leonard I (2017) Blood on the tracks: hematopoietic stem cell-endothelial cell interactions in homing and engraftment. J Mol Med (Berl) 95:809-819

Showing the most recent 10 out of 98 publications